Associated Papers
Thrombophilia-Related Single Nucleotide Variants and Altered Coagulation Parameters in a Cohort of Mexican Women with Recurrent Pregnancy Loss.
León-Madero LF et al.
Diagnostics (basel, Switzerland), 2025
Genetic determinants of activated factor VII-antithrombin plasma levels and mortality in patients with coronary artery disease.
Osti N et al.
Thrombosis Research, 2025
Rare bleeding disorders: Real-world data from a Spanish tertiary hospital.
Martínez-Carballeira D et al.
Blood Cells, Molecules & Diseases, 2024
Factor VII R353Q (rs6046), FGA A6534G (rs6050), and FGG C10034T (rs2066865) Gene Polymorphisms and Risk of Recurrent Pregnancy Loss in Iranian Women.
Kavosh Z et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion, 2024
The prevalence and linkage disequilibrium of 21 genetic variations related to thrombophilia, folate cycle, and hypertension in reproductive age women of Rostov region (Russia).
Bordaeva OY et al.
Annals of Human Genetics, 2024
ATR1 A1166C (rs5186), FII G20210A (rs1799963), FV G1691A (rs6025), FXIII 97G > T (rs11466016) and MTHFR A1298C (rs1801131) polymorphisms and the risk of ST-elevation myocardial infarction in young Mexican individuals.
Isordia-Salas I et al.
Molecular Biology Reports, 2024
Molecular Genetic Analysis of Russian Patients with Coagulation Factor FVII Deficiency.
Pshenichnikova O et al.
Genes, 2023
Acute Thrombotic Events in Association With Coronavirus Disease of 2019 Immunization as Initial Presentation of Congenital Factor VII Deficiency.
Trillo A et al.
Journal of Pediatric Hematology/oncology, 2023
Utility of ACMG classification to support interpretation of molecular genetic test results in patients with factor VII deficiency.
Alesci RS et al.
Frontiers in Medicine, 2023
Genetic Variants Associated with High Susceptibility of Premature Ischemic Stroke.
Isordia-Salas I et al.
Journal of the Renin-angiotensin-aldosterone System : Jraas, 2023
High Prevalence of Congenital Factor VII (FVII) Deficiency in Adolescent Females with Heavy Menstrual Bleeding and Iron Deficiency Anemia.
Trillo A et al.
Journal of Pediatric and Adolescent Gynecology, 2022
Novel heterozygous F7 gene mutation (c. C1286T) associated with congenital factor VII deficiency: A case report and literature review.
Tang H et al.
Journal of Clinical Laboratory Analysis, 2022
Ethnic Diversity and Warfarin Pharmacogenomics.
Asiimwe IG et al.
Frontiers in Pharmacology, 2022
Contribution of factor VII polymorphisms to coagulopathy in patients with isolated traumatic brain injury.
Fang J et al.
Clinical Neurology and Neurosurgery, 2021
FVII gene R353Q polymorphism and coronary heart disease: a meta-analysis including 3258 subjects.
Li YY et al.
Journal of Thrombosis and Thrombolysis, 2021
Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization.
Cassel A et al.
Research and Practice in Thrombosis and Haemostasis, 2021
Determining the association of thrombophilic gene polymorphisms with recurrent pregnancy loss in Iranian women.
Khorshidi F et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 2020
Association Between R353Q (rs6046) Polymorphism in Factor VII with Coronary Heart Disease.
Li F et al.
International Heart Journal, 2020
The EAHAD blood coagulation factor VII variant database.
Giansily-Blaizot M et al.
Human Mutation, 2020
A rare case of Glanzmann's thrombasthenia and factor VII deficiency due to a combination of pathogenic and non-pathogenic gene variants.
Deshpande R et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia, 2020
Factor VII Gene Defects: Review of Functional Studies and Their Clinical Implications
Shahbazi S et al.
Iranian Biomedical Journal, 2019
Investigation of potential biomarkers for thrombosis related diseases in Turkish Cypriot population.
Ergoren MC et al.
International Journal of Biological Macromolecules, 2019
The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarin.
Shaul C et al.
European Journal of Clinical Pharmacology, 2019
Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy.
Al-Eitan LN et al.
Pharmacogenomics and Personalized Medicine, 2019
Polymorphism of R353Q (rs6046) in factor VII and the risk of myocardial infarction: A systematic review and meta-analysis.
Huang H et al.
Medicine, 2018
Genetic polymorphisms in the FVII gene is associated with lower extremity deep venous thrombosis: A case-control study.
Liu JW et al.
Journal of Cellular Biochemistry, 2018
Warfarin Dose Model for the Prediction of Stable Maintenance Dose in Indian Patients.
Gaikwad T et al.
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/hemostasis, 2018
Expanded carrier screening and preimplantation genetic diagnosis in a couple who delivered a baby affected with congenital factor VII deficiency.
He WB et al.
Bmc Medical Genetics, 2018
Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.
Olson NC et al.
Journal of Thrombosis and Haemostasis : Jth, 2018
Primary prophylaxis for children with severe congenital factor VII deficiency - Clinical and laboratory assessment.
Kuperman AA et al.
Blood Cells, Molecules & Diseases, 2017
A Prothrombotic Score Based on Genetic Polymorphisms of the Hemostatic System Differs in Patients with Ischemic Stroke, Myocardial Infarction, or Peripheral Arterial Occlusive Disease.
Herm J et al.
Frontiers in Cardiovascular Medicine, 2017
Contribution of inherited thrombophilia to recurrent miscarriage in the Polish population.
Wolski H et al.
Ginekologia Polska, 2017
Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation.
Corsetti JP et al.
Atherosclerosis, 2016
Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.
Miyata N et al.
General Thoracic and Cardiovascular Surgery, 2016
[Polymorphism (353)R>Q of Gene of Blood Clotting Factor FVII and Plasma Hemostasis].
Bairova TA et al.
Genetika, 2016
Correlation between factor VII and PAI-1 genetic variants and recurrent miscarriage.
Barlik M et al.
Ginekologia Polska, 2016
Association of folate metabolism gene polymorphisms and pulmonary embolism: A case-control study of West-Siberian population.
Karmadonova NA et al.
Thrombosis Research, 2015
Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study.
Yamada Y et al.
Biomedical Reports, 2015
Can Genetic Analysis of Putative Blood Alzheimer's Disease Biomarkers Lead to Identification of Susceptibility Loci?
Barber RC et al.
Plos One, 2015
[Correlation between polymorphisms in the coagulation factor VII gene hypervariable region 4 site and the risk of coronary heart disease in population with different ethnic backgrounds: a Meta-analysis].
Wang LL et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi, 2013
Factor VII levels, R353Q and -323P0/10 Factor VII variants, and the risk of acute coronary syndrome among Arab-African Tunisians.
Ben-Hadj-Khalifa S et al.
Molecular Biology Reports, 2013
Genetic polymorphisms and the risk of myocardial infarction in patients under 45 years of age.
Sakowicz A et al.
Biochemical Genetics, 2013
Considering the vascular hypothesis for the pathogenesis of small intestinal atresia: a case control study of genetic factors.
Gupta T et al.
American Journal of Medical Genetics. Part A, 2013
Contribution of coagulation factor VII R353Q, -323P0/10 and HVR4 polymorphisms to coronary artery disease in Tunisians.
Ben-Hadj-Khalifa S et al.
Journal of Thrombosis and Thrombolysis, 2013
Factor VII deficiency: a single-center experience.
Salcioglu Z et al.
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/hemostasis, 2012
Prothrombotic gene polymorphisms and plasma factors in young North Indian survivors of acute myocardial infarction.
Dogra RK et al.
Journal of Thrombosis and Thrombolysis, 2012
[Association between gene polymorphisms and myocardial infarction in Han Chinese of Yunnan province].
Qi L et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2012
Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers.
Mlynarsky L et al.
European Journal of Clinical Pharmacology, 2012
Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis.
Kruthika-Vinod TP et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 2012